A detailed history of Royal Bank Of Canada transactions in Pro Mis Neurosciences Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 713 shares of PMN stock, worth $819. This represents 0.0% of its overall portfolio holdings.

Number of Shares
713
Previous 713 -0.0%
Holding current value
$819
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$1.52 - $6.19 $2,705 - $11,018
-1,780 Reduced 71.4%
713 $1,000
Q2 2023

Aug 14, 2023

BUY
$3.7 - $8.14 $1,084 - $2,385
293 Added 13.32%
2,493 $9,000
Q1 2023

May 15, 2023

SELL
$4.06 - $5.71 $247 - $348
-61 Reduced 2.7%
2,200 $10,000
Q4 2022

Feb 14, 2023

BUY
$4.33 - $6.29 $4,715 - $6,849
1,089 Added 92.92%
2,261 $9,000
Q3 2022

Nov 14, 2022

BUY
$4.99 - $9.25 $5,848 - $10,841
1,172 New
1,172 $7,000

Others Institutions Holding PMN

About ProMIS Neurosciences Inc.


  • Ticker PMN
  • Exchange OTC
  • Description
  • ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms t...
More about PMN
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.